William Blair research analyst Matt Phipps was quoted in Barron’s following the announcement of a new Medicare drug pricing structure by the Biden administration.
Equity Research
Matt Phipps Reacts to Medicare Drug Pricing Announcement in Barron’s
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Sterling Infrastructure, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Sterling Infrastructure, Inc. (STRL $177.15), which provides site development and construction services for the data center, e-commerce, semiconductor, transportation, and residential end-markets.
-
-
Cboe Global Markets, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Cboe Global Markets, Inc. (CBOE $190.84), a leading derivatives and securities exchange network that provides trading, clearing, data, and technology solutions to a broad range of market participants globally.